PROTOCOLS FOR TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

• 收藏
• 分享

专利权人:

Neuralstem, Inc.

发明人:

JOHE, Karl, K.

申请号：

EP20150809513

公开号：

EP3154545(A1)

申请日:

2015.06.15

申请国别(地区):

欧洲专利局

年份:

2017

代理人:

摘要：

Although it is known that certain benzylpiperazine-aminopyridines or open chain forms thereof are effective in stimulating neural growth in in vitro tests, it has now been surprisingly found that administering these compounds in a dosage range of 10 mg/day-130 mg/day over 25-35 days is effective in treating Major Depressive Disorder (MDD) such that statistically significant results can be obtained with samples of only six subjects.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/